Pfizer Inc (PFE)

$28.08 +0.31 (1.12%)
Market Cap 153.76B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.54
Forward PE 9.27
Profit Margin 12.42%
Debt to Equity Ratio 0.75
Volume 43,282,504
Avg Vol 45,775,789
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 96%
Beta 0.47
Analysts Sell
Price Target $28.98

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
Willieberich
Willieberich Mar. 31 at 8:53 PM
$PFE 27 now is great support .26.50 is next .but this is building great structure..
0 · Reply
Willieberich
Willieberich Mar. 31 at 8:51 PM
$PFE very nice close! Still needs to go to 28.20 or so .then come back to retest 28 .to start creating support at 28 .very nice tho .
0 · Reply
RunnerSignals
RunnerSignals Mar. 31 at 8:36 PM
52 week highs breakout stocks ​$APLS $CNTA $UNIT $BTE $PFE breakouts show selective accumulation RSI elevated yet volume confirms institutions adding not distributing
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Mar. 31 at 8:13 PM
$PFE Comical how there trying to bring this to $28 AH lol
0 · Reply
JBS_84
JBS_84 Mar. 31 at 8:06 PM
$PFE Looks ok, should be good to go. Wider market doesn't really matter much.
0 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 31 at 8:03 PM
$PFE holy shit we closed over 28
0 · Reply
Typecheck
Typecheck Mar. 31 at 8:03 PM
$PFE End of Q1. The banks really want to have a good looking quarter by putting lip stick on a pig.
1 · Reply
JBS_84
JBS_84 Mar. 31 at 7:42 PM
$PFE Stupid 28.03 pivot. If we get past it it will really go
0 · Reply
TycoonYanky
TycoonYanky Mar. 31 at 7:39 PM
$PFE whole market is pumped and this shit is almost flat.. 💩
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Mar. 31 at 6:51 PM
$PFE Get this 🐷 oinking
1 · Reply
Latest News on PFE
Pharma Offers Defensive Plays in an Uncertain Market. Charts Say Buy These 2 Stocks.

Mar 30, 2026, 10:44 AM EDT - 1 day ago

Pharma Offers Defensive Plays in an Uncertain Market. Charts Say Buy These 2 Stocks.

GSK LLY NVO PPH

Pfizer: Why Wall Street Habitually Overestimates Target Price

Mar 27, 2026, 3:48 PM EDT - 4 days ago

Pfizer: Why Wall Street Habitually Overestimates Target Price

Why Pfizer Remains A Strong Buy In 2026

Mar 27, 2026, 10:46 AM EDT - 4 days ago

Why Pfizer Remains A Strong Buy In 2026

Pfizer: Undervalued High-Yield Giant With A Pipeline Built For The Next Decade

Mar 25, 2026, 9:15 AM EDT - 6 days ago

Pfizer: Undervalued High-Yield Giant With A Pipeline Built For The Next Decade

Pfizer: Time To Buy The Turnaround

Mar 25, 2026, 2:06 AM EDT - 6 days ago

Pfizer: Time To Buy The Turnaround

Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

Mar 24, 2026, 10:00 AM EDT - 7 days ago

Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive

Mar 23, 2026, 12:46 PM EDT - 8 days ago

An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive

VALN

Valneva-Pfizer Lyme Shot Stumbles Yet Keeps Regulatory Path Alive

Mar 23, 2026, 10:35 AM EDT - 8 days ago

Valneva-Pfizer Lyme Shot Stumbles Yet Keeps Regulatory Path Alive

VALN

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

Mar 23, 2026, 9:36 AM EDT - 8 days ago

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

VALN

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

Mar 23, 2026, 7:07 AM EDT - 8 days ago

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

VALN

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial

Mar 23, 2026, 7:02 AM EDT - 8 days ago

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial

VALN

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

Mar 23, 2026, 6:47 AM EDT - 8 days ago

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

VALN

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

Mar 23, 2026, 6:45 AM EDT - 8 days ago

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

VALN

5 ‘Healthy' Dividends Paying Up To 14.1%

Mar 22, 2026, 9:45 AM EDT - 9 days ago

5 ‘Healthy' Dividends Paying Up To 14.1%

ARE BME DOC HQH

Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

Mar 20, 2026, 4:30 PM EDT - 11 days ago

Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer

Mar 19, 2026, 6:45 AM EDT - 12 days ago

TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer

TrumpRx lists many medicines at prices higher than paid in UK

Mar 18, 2026, 2:23 PM EDT - 13 days ago

TrumpRx lists many medicines at prices higher than paid in UK

ABBV AMGN AZN BMY GILD GSK JNJ

Pfizer: I'm Still Expecting A Massive Rebound

Mar 18, 2026, 9:00 AM EDT - 13 days ago

Pfizer: I'm Still Expecting A Massive Rebound

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

Mar 17, 2026, 7:49 AM EDT - 14 days ago

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Mar 17, 2026, 6:45 AM EDT - 14 days ago

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Expect Pfizer To Comeback: Take The Dividend While Waiting For Capital Appreciation

Mar 13, 2026, 5:01 PM EDT - 18 days ago

Expect Pfizer To Comeback: Take The Dividend While Waiting For Capital Appreciation

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

Mar 9, 2026, 7:27 AM EDT - 22 days ago

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

Mar 9, 2026, 6:45 AM EDT - 22 days ago

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (March 2026)

Mar 7, 2026, 8:15 AM EST - 24 days ago

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (March 2026)

ADP ARCC BX CAG GLPI MPLX MSFT

Wall Street Breakfast Podcast: India To Buy Russian Oil As War Disrupts Supplies

Mar 6, 2026, 6:05 AM EST - 25 days ago

Wall Street Breakfast Podcast: India To Buy Russian Oil As War Disrupts Supplies

AMD GOOG GOOGL LLY NVDA NVO

China approves Pfizer GLP-1 drug for weight management

Mar 6, 2026, 12:40 AM EST - 25 days ago

China approves Pfizer GLP-1 drug for weight management

Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund

Mar 5, 2026, 4:48 PM EST - 25 days ago

Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund

Seven S&P500 Ideal 'Safer' March Dividend Dogs

Mar 4, 2026, 11:31 AM EST - 27 days ago

Seven S&P500 Ideal 'Safer' March Dividend Dogs

AMCR ARE BBY BEN BXP CAG CCI

Pfizer's Portfolio Renewal In Progress - High Yields For The Patient

Mar 4, 2026, 9:09 AM EST - 27 days ago

Pfizer's Portfolio Renewal In Progress - High Yields For The Patient

NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals

Mar 4, 2026, 8:55 AM EST - 27 days ago

NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals

SMWB

Pfizer's Quiet Cash Comeback

Mar 3, 2026, 9:50 AM EST - 4 weeks ago

Pfizer's Quiet Cash Comeback

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields

Mar 3, 2026, 8:10 AM EST - 4 weeks ago

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields

PRGO XRAY

Pfizer Inc. (PFE) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Mar 2, 2026, 1:27 PM EST - 4 weeks ago

Pfizer Inc. (PFE) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Pfizer CEO flags issues with FDA's vaccine leadership

Mar 2, 2026, 11:14 AM EST - 4 weeks ago

Pfizer CEO flags issues with FDA's vaccine leadership

The High Dividend Yield Bull Market: 3 Compelling 6% Yields

Mar 2, 2026, 4:51 AM EST - 4 weeks ago

The High Dividend Yield Bull Market: 3 Compelling 6% Yields

ABBV AMGN AVGO BTI DIV ENB GTY

14 Ideal 'Safer' Dividend Buys From 29 Of 69 March Graham Value All-Stars (GVAS)

Mar 1, 2026, 8:10 AM EST - 4 weeks ago

14 Ideal 'Safer' Dividend Buys From 29 Of 69 March Graham Value All-Stars (GVAS)

ARCC BBVA E EQNR ETD FINV GSL

PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

Feb 27, 2026, 10:00 AM EST - 4 weeks ago

PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

5 'Safer' Dividend Buys In Barron's 23 Better February Bets Than T-Bills

Feb 26, 2026, 7:48 AM EST - 4 weeks ago

5 'Safer' Dividend Buys In Barron's 23 Better February Bets Than T-Bills

BBY CAG EQR FRT KEY KMI LYB

U.S. FDA Grants Full Approval to Pfizer's BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer

Feb 24, 2026, 2:29 PM EST - 5 weeks ago

U.S. FDA Grants Full Approval to Pfizer's BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer

Pfizer Adds Sciwind As China Partner For New Weight Loss Drug

Feb 24, 2026, 7:45 AM EST - 5 weeks ago

Pfizer Adds Sciwind As China Partner For New Weight Loss Drug

Pfizer in diabetes drug deal with Sciwind Biosciences

Feb 23, 2026, 10:26 PM EST - 5 weeks ago

Pfizer in diabetes drug deal with Sciwind Biosciences

US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost

Feb 23, 2026, 3:15 PM EST - 5 weeks ago

US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost

MRK MRNA

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Feb 23, 2026, 10:00 AM EST - 5 weeks ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Pfizer: A Risky 6.3% Yield For Income-Oriented Investors

Feb 20, 2026, 11:47 PM EST - 5 weeks ago

Pfizer: A Risky 6.3% Yield For Income-Oriented Investors

Is There 25% Downside For Pfizer Stock?

Feb 18, 2026, 12:00 PM EST - 5 weeks ago

Is There 25% Downside For Pfizer Stock?

Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts Its Turnaround Game

Feb 18, 2026, 11:30 AM EST - 5 weeks ago

Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts Its Turnaround Game

Pfizer: The Rebound Looks Unsustainable

Feb 17, 2026, 5:42 PM EST - 5 weeks ago

Pfizer: The Rebound Looks Unsustainable

Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer

Feb 17, 2026, 6:45 AM EST - 6 weeks ago

Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer

Prices, pipelines and patent cliffs: Inside pharma's big reset

Feb 13, 2026, 6:13 AM EST - 6 weeks ago

Prices, pipelines and patent cliffs: Inside pharma's big reset

AMGN LLY NVO

These 32 favorite stocks signal the bull market is running on fumes

Feb 12, 2026, 8:05 AM EST - 6 weeks ago

These 32 favorite stocks signal the bull market is running on fumes

AAPL ABT ADBE AMGN AVGO BAC BK

Willieberich
Willieberich Mar. 31 at 8:53 PM
$PFE 27 now is great support .26.50 is next .but this is building great structure..
0 · Reply
Willieberich
Willieberich Mar. 31 at 8:51 PM
$PFE very nice close! Still needs to go to 28.20 or so .then come back to retest 28 .to start creating support at 28 .very nice tho .
0 · Reply
RunnerSignals
RunnerSignals Mar. 31 at 8:36 PM
52 week highs breakout stocks ​$APLS $CNTA $UNIT $BTE $PFE breakouts show selective accumulation RSI elevated yet volume confirms institutions adding not distributing
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Mar. 31 at 8:13 PM
$PFE Comical how there trying to bring this to $28 AH lol
0 · Reply
JBS_84
JBS_84 Mar. 31 at 8:06 PM
$PFE Looks ok, should be good to go. Wider market doesn't really matter much.
0 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 31 at 8:03 PM
$PFE holy shit we closed over 28
0 · Reply
Typecheck
Typecheck Mar. 31 at 8:03 PM
$PFE End of Q1. The banks really want to have a good looking quarter by putting lip stick on a pig.
1 · Reply
JBS_84
JBS_84 Mar. 31 at 7:42 PM
$PFE Stupid 28.03 pivot. If we get past it it will really go
0 · Reply
TycoonYanky
TycoonYanky Mar. 31 at 7:39 PM
$PFE whole market is pumped and this shit is almost flat.. 💩
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Mar. 31 at 6:51 PM
$PFE Get this 🐷 oinking
1 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 31 at 6:44 PM
$PFE pinned
1 · Reply
morgangj
morgangj Mar. 31 at 6:27 PM
$PFE UNDERVALUED. $40.00.
1 · Reply
Willieberich
Willieberich Mar. 31 at 6:22 PM
$PFE big wall of sellers at 28 .we get through that ! We move forward towards 29 .nice and slow ..building support on the way up ..very nice...good luck people .
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Mar. 31 at 5:54 PM
$PFE $MRK $BMY $LLY $SPY
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Mar. 31 at 5:29 PM
$PFE - Party for thee, not for me
3 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 31 at 5:21 PM
$PFE it’s funny how this stock completely ignores the market most days
0 · Reply
SPG565
SPG565 Mar. 31 at 5:07 PM
$MU LOWER valuation than $PFE Ridiculous
1 · Reply
EingeLTrade
EingeLTrade Mar. 31 at 5:06 PM
Watch out $PFE above $30!
0 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 31 at 4:46 PM
$PFE absolutely comical
2 · Reply
LaurieSmitha
LaurieSmitha Mar. 31 at 4:31 PM
$OTH https://www.globenewswire.com/news-release/2026/03/30/3265015/0/en/O%EF%AC%80-The-Hook-Yachts-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-and-Operating-Results.html Off The Hook Yachts Reports Fourth Quarter and Full-Year 2025 Financial and Operating Results https://www.stocktitan.net/news/OTH/off-the-hook-yachts-reports-fourth-quarter-and-full-year-2025-h8j5rdpts0ui.html $PFE $CNTA $NIO $MU
0 · Reply
RichMitch
RichMitch Mar. 31 at 4:31 PM
$VRDN 🔥 💪😉 $SPY $UNH $PFE $MRNA
0 · Reply
JBS_84
JBS_84 Mar. 31 at 4:28 PM
$PFE ~27.93 retest complete. Next break back over 28.
0 · Reply